FutureFuel Corp. FF

Healthcare SIC 2860 - Industrial Organic Chemicals NAICS Manufacturing › Chemical Manufacturing › Basic Chemical Manufacturing › Other Basic Organic Chemical Manufacturing derived NYSE

FutureFuel Corp. ("FutureFuel," the "Company," "we," "us," or "our," and includes our wholly-owned subsidiaries) is a Delaware corporation operating primarily through our subsidiary, FutureFuel Chemical Company. We manufacture a diverse portfolio of inorganic chemicals, bio-based specialty chemicals, and biofuels in our integrated facility in Batesville, Arkansas.

FutureFuel is publicly traded on the New York Stock Exchange ("NYSE") under the ticker symbol "FF". Our headquarters are located at our facility in Batesville, Arkansas.

Unless noted otherwise, all financial figures in this report are presented in thousand United States dollars, excluding per-share data.

We maintained a consistent commitment to returning value to our shareholders.

Last close 5.71 2026-10-23
Market cap $250.5M 2026-06-30 share count
52-week range 3.09 - 6.99

Valuation FY2025 figures against the last close

P/S2.6x
P/E—
P/FCF—
EV/EBITDA—
Dividend yield4.2%
Diluted EPS-1.13

Where the revenue comes from as reported in the latest 10-K

Revenue by segment

  • Chemicals
  • Biofuels
Revenue by segment, 2 categories over 3 years. The same figures are in the table below. FY2025 Chemicals, FY2025: 59.6M (62.2%) 62% Chemicals Biofuels, FY2025: 36.2M (37.8%) 38% Biofuels FY2024 Chemicals, FY2024: 80M (32.9%) 33% Biofuels, FY2024: 163.3M (67.1%) 67% FY2023 Chemicals, FY2023: 79.3M (21.5%) 22% Biofuels, FY2023: 288.9M (78.5%) 78%
Segment FY2025FY2024FY2023
Chemicals $59.6M $80.0M $79.3M
Biofuels $36.2M $163.3M $288.9M

As the company reported it, from the “Note 21 - Segment Information - Summary of Business by Segment (Details)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Segments are the filer's own reporting structure, which is a decision about how it runs itself rather than a standard taxonomy: two companies in the same industry routinely divide themselves along different lines, so these are worth reading down a single company rather than across two. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $95.7M$243.3M$368.2M$396.0M$321.4M$204.5M$205.2M$291.0M$275.0M$253.2M
Cost of revenue ———————$191.8M$224.2M$191.7M
Gross profit -$39.4M$19.6M$41.0M$29.0M$23.5M$31.3M$74.1M$73.4M$20.3M$46.9M
R&D $3.9M$4.0M$4.4M$3.4M$3.5M$3.0M$3.2M$3.5M$3.7M$2.7M
SG&A $9.7M$9.3M$9.2M$8.0M——————
Total operating expenses $13.6M$13.3M$13.6M$11.4M$10.6M$9.0M$8.8M$10.0M$10.4M$10.3M
Operating income -$53.0M$6.4M$27.4M$17.5M$12.9M$22.3M$65.3M$63.4M$9.9M$36.5M
Interest expense $153.0K$138.0K$138.0K$128.0K$131.0K$151.0K$173.0K$173.0K$172.0K$173.0K
Pre-tax income -$49.2M$16.3M$37.4M$13.7M$15.9M$31.8M$79.8M$60.2M$16.6M$40.8M
Income tax $165.0K$792.0K$1.0K$1.5M$10.3M$14.8M$8.4M$7.0M$6.9M$15.5M
Net income -$49.4M$15.5M$37.4M$15.2M$26.3M$46.6M$88.2M$53.2M$23.5M$56.3M
EPS, basic -1.130.350.850.350.601.062.021.220.541.29
EPS, diluted -1.130.350.850.350.601.062.021.220.541.29
Shares, diluted (wtd. avg.) 43.9M43.8M43.8M43.8M43.8M43.7M43.7M43.7M43.7M43.5M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $51.3M$109.5M$219.4M$175.6M$137.5M$198.1M$243.3M$215.0M$114.6M$199.3M
Short-term investments ——$0$37.1M$47.2M$64.4M$73.6M$79.9M$120.7M$106.1M
Receivables $9.4M$21.9M$28.4M$26.2M$29.3M$21.4M$110.3M$16.3M$22.0M$24.4M
Inventory $21.3M$20.6M$25.4M$26.8M$26.9M$33.9M$37.6M$39.3M$43.8M$52.1M
Total current assets $100.5M$164.8M$290.5M$273.8M$255.8M$342.6M$480.9M$362.3M$310.4M$405.3M
Property, plant and equipment $86.8M$78.5M$72.7M$76.9M$82.9M$91.5M$98.6M$103.6M$109.7M$118.2M
Other intangibles ————$0$1.4M$1.4M$1.4M$1.4M$1.4M
Total assets $192.2M$247.7M$367.1M$356.0M$344.3M$441.3M$586.5M$471.2M$425.6M$529.0M
Accounts payable ——$22.2M$28.5M$14.9M$12.5M$61.3M$20.0M$18.4M$22.8M
Total current liabilities $17.7M$33.3M$41.3M$56.1M$35.1M$33.0M$82.8M$39.5M$35.3M$144.0M
Total liabilities $37.5M$41.9M$57.2M$73.0M$55.4M$69.4M$119.4M$82.1M$74.0M$196.2M
Retained earnings -$49.1M$383.0K$27.4M$508.0K$6.3M$89.5M$184.6M$106.9M$61.2M$48.2M
Total equity $154.7M$205.8M$309.9M$283.0M$288.9M$371.9M$467.1M$389.1M$351.6M$332.8M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow -$28.7M$24.8M$21.3M$52.5M$44.1M$96.4M$34.6M$85.6M$39.3M$91.0M
Depreciation and amortisation $9.7M$9.2M$10.3M$10.5M$10.5M$11.2M$12.1M$11.2M$11.6M$10.8M
Stock-based compensation $1.0M$359.0K$0$46.0K$0$49.0K$21.0K$357.0K$998.0K$1.9M
Capital expenditure $17.2M$14.7M$6.0M$4.8M$1.5M$4.5M$7.0M$4.9M$3.6M$4.5M
Investing cash flow -$18.6M-$14.8M$33.0M-$3.8M$15.0M$474.0K$4.2M$25.4M-$13.2M-$35.2M
Financing cash flow -$10.9M-$119.9M-$10.5M-$10.5M-$119.7M-$142.1M-$10.5M-$10.7M-$110.8M-$10.5M
Dividends paid $10.5M$119.9M$10.5M$10.5M$119.9M$141.7M$10.5M$10.5M$110.7M$10.5M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001437749-26-027325.

Plot the figures US dollars

  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -200M 0 200M 400M Revenue, FY2016: 253.2M Gross profit, FY2016: 46.9M Net income, FY2016: 56.3M Revenue, FY2017: 275M Gross profit, FY2017: 20.3M Net income, FY2017: 23.5M Revenue, FY2018: 291M Gross profit, FY2018: 73.4M Net income, FY2018: 53.2M Revenue, FY2019: 205.2M Gross profit, FY2019: 74.1M Net income, FY2019: 88.2M Revenue, FY2020: 204.5M Gross profit, FY2020: 31.3M Net income, FY2020: 46.6M Revenue, FY2021: 321.4M Gross profit, FY2021: 23.5M Net income, FY2021: 26.3M Revenue, FY2022: 396M Gross profit, FY2022: 29M Net income, FY2022: 15.2M Revenue, FY2023: 368.2M Gross profit, FY2023: 41M Net income, FY2023: 37.4M Revenue, FY2024: 243.3M Gross profit, FY2024: 19.6M Net income, FY2024: 15.5M Revenue, FY2025: 95.7M Gross profit, FY2025: -39.4M Net income, FY2025: -49.4M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $253.2M $275.0M $291.0M $205.2M $204.5M $321.4M $396.0M $368.2M $243.3M $95.7M
Gross profit $46.9M $20.3M $73.4M $74.1M $31.3M $23.5M $29.0M $41.0M $19.6M -$39.4M
Net income $56.3M $23.5M $53.2M $88.2M $46.6M $26.3M $15.2M $37.4M $15.5M -$49.4M

Recent filings and events

  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Other event Item 8.01
  • Other event Item 8.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Results announced Item 2.02
  • Other event Item 8.01
  • Other event Item 8.01
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Results announced Item 2.02
  • Other event Item 8.01
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2860

TickerCompanyMarket capP/ERevenue growth
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC $24.02B — -5.2%
LYB LyondellBasell Industries N.V. $21.47B — -9.7%
WLK WESTLAKE CORP $8.25B — -8.0%
NEU NEWMARKET CORP $8.01B 19.6x -2.2%
SXT SENSIENT TECHNOLOGIES CORP $5.65B 42.0x 3.5%
REX REX AMERICAN RESOURCES Corp $1.32B 15.9x 1.2%
GPRE Green Plains Inc. $979.9M — 16.0%
WLKP Westlake Chemical Partners LP $745.5M — 2.7%